C J Melief - Concepedia

Author

C J Melief

Also Known As

C J M MELIEF, C J M Melief, C J Melief, C Melief, C. J. M. Melief, C. Melief, C.J.M Melief, C.J.M. Melief, CJM Melief, J Borst

Publications

Citations

H-Index

Concepts

All Affiliations

Dutch Blood Transfusion Society Oncode Institute The Netherlands Cancer Institute Leiden University University of Amsterdam

About

C J Melief is an author at Dutch Blood Transfusion Society specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	24	2.6K
2	Cell Biology	12	12	1.6K
3	Allergy	5	5	1.3K
4	Cellular Physiology	2	2	52
5	Health Sciences	1	1	13

C J Melief

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. Alessandro Sette, Antonella Vitiello, B Reherman, The Journal of Immunology HistocompatibilityHla ImmunogeneticsImmunologyImmunodominanceAntigen Processing	1994	844
Tumorigenicity of cells transformed by adenovirus type 12 by evasion of T-cell immunity René Bernards, Peter I. Schrier, Ada Houweling, Nature MedicineImmunologyPathologyT Cell ImmunityAdenovirus Type 12	1983	352
Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide. W. Martin Kast, L. Roux, J Curren, Proceedings of the National Academy of Sciences VaccinationAllergyFree Synthetic PeptideImmunologyVirus-specific Cytotoxic T	1991	328
Involvement of c-myc in MuLV-induced T cell lymphomas in mice: frequency and mechanisms of activation. Gerard C.M. Selten, H. T. M. Cuypers, Maarten Zijlstra, The EMBO Journal Lymphoid NeoplasiaAutoimmune DiseaseImmunologyTumor ImmunityPathology	1984	235
Decreased expression of signal-transducing zeta chain in peripheral T cells and natural killer cells in patients with cervical cancer. Koji Kono, Maaike E. Ressing, Remco M.P. Brandt, PubMed Peripheral T CellsTumor Necrosis FactorCancer ImmunosurveillanceCervical CancerImmunology	1996	166
Cooperation between cytotoxic and helper T lymphocytes in protection against lethal Sendai virus infection. Protection by T cells is MHC-restricted and MHC-regulated; a model for MHC-disease associations. W. Martin Kast, A. M. Bronkhorst, Leo P. de Waal, The Journal of Experimental Medicine Helper TAdaptive Immune SystemHumoral ResponseImmune RegulationImmunology	1986	137
Regulation of the cytotoxic T lymphocyte response against Sendai virus analyzed with H-2 mutants. Leo P. de Waal, W. Martin Kast, Roger W. Melvold, The Journal of Immunology Sendai VirusPathogenesisImmunologyAntiviral ResponseVirology	1983	63
High steady-state levels of p53 are not a prerequisite for tumor eradication by wild-type p53-specific cytotoxic T lymphocytes. Michel Vierboom, Suzanne Zwaveling, Bos GMJ, PubMed ImmunologyPathologyHigh Steady-state LevelsImmunotherapyElevated P53 Synthesis	2000	59
Further evidence against random polyclonal antibody formation in mice with lupus-like graft-<i>vs</i>-host disease. F M van Rappard-van der Veen, U Kiesel, Lambert G. Poels, The Journal of Immunology	1984	49
Lack of correlation between levels of MHC class I antigen and susceptibility to lysis of small cellular lung carcinoma (SCLC) by natural killer cells Nico J. Stam, W. Martin Kast, Arie C. Voordouw, Lung Cancer HistocompatibilityCancer ImmunosurveillanceMhc ClassImmunologyPathology	1990	46

Page 1